A randomised study evaluating the efficacy and safety of sorafenib compared to placebo in metastatic breast cancer

Update Il y a 4 ans
Reference: ISRCTN72153214

Woman Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Not provided at time of registration


Inclusion criteria

  • Locally Recurrent or Metastatic Breast Cancer

Links